Skip to main content
SpringerLink
Log in

How Far Should Blood Pressure Be Lowered?

  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Amery A. Birkenhäger WH, Brixko P, Bulpitt C, Clement D. et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly Trial. Lancet I: 1349–1354, 1985

    Article  Google Scholar 

  • Amery A, Birkenhäger WH, Brixko P, Bulpitt C, Clement D. et al. Efficacy of antihypertensive drug treatment according to age, sex, blood pressure, and previous cardiovascular disease in patients over the age of 60. Lancet 2: 589–592, 1986

    Article  PubMed  CAS  Google Scholar 

  • Anderson TW. Re-examination of some of the Framingham blood pressure data. Lancet 2: 1139–1141, 1978

    Article  PubMed  CAS  Google Scholar 

  • Caird FI, Andrews GR, Kennedy RD. Effect of postu re on blood pressure in the elderly. British Heart Journal 35: 527–530, 1973

    Article  PubMed  CAS  Google Scholar 

  • Coope J, Warrender TS. Randomized trial of treatment of hypertension in primary care. British Medical Journal 293: 1145–1151, 1986

    Article  PubMed  CAS  Google Scholar 

  • Cruickshank JM, Thorp JM, Zacharias FJ. Benefit and potential harm of lowering high blood pressure. Lancet I: 581–584, 1987

    Article  Google Scholar 

  • Editorial. How far to lower blood pressure? Lancet 2: 251–252, 1987

    Google Scholar 

  • Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-up Program. 1. Reduction in mortality of persons with high blood pressure including mild hypertension. Journal of the American Medical Association 242: 2562–2571, 1979

    Article  Google Scholar 

  • IPPPSH Collaborative Group. Cardiovascular risk and risk factors in a randomized trial of treatment based on the betablocker oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH). Journal of Hypertension 3: 379–392, 1985

    Article  Google Scholar 

  • Jansen PAF, Schulte BPM, Gribnau FWJ. Cerebral ischaemia and stroke as side effects of antihypertensive treatment: special danger in the elderly. A review of cases reported in the literature. Netherlands Journal of Medicine 30: 193–201, 1987

    PubMed  CAS  Google Scholar 

  • Management Committee of the Australian Therapeutic Trial in Mild Hypertension. The Australian therapeutic trial in mild hypertension. Lancet I: 1261–1267, 1980

    Google Scholar 

  • Medical Research Council Working Party. M.R.C. trial of treatment of hypertension: principal results. British Medical Journal 291: 97–104, 1985

    Article  Google Scholar 

  • Multiple Risk Factor Intervention Trial Research Group. Multiple risk factor intervention trial. Journal of the American Medical Association 248: 1465–1477, 1982

    Article  Google Scholar 

  • Samuelsson O, Wilhelmsen L, Andersson OK, Pennert K, Berglund G. Cardiovascular morbidity in relation to change in blood pressure and serum cholesterol levels in treated hypertension. Results from the Primary Prevention Trial in Goteborg, Sweden. Journal of the American Medical Association 258: 1768–1776, 1987

    Article  PubMed  CAS  Google Scholar 

  • Stewart IMcD. Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension. Lancet I: 861–866, 1979

    Article  Google Scholar 

  • Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114mm Hg, Journal of the American Medical Association 213: 1143–1152, 1970

    Article  Google Scholar 

  • Wilhelmsen L, Berglund G, Elmfeldt D, Fitzsimons T, Holzgreve H. et al. Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. Journal of Hypertension 5: 561–572, 1987

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Erasmus University and Zuiderziekenhuis, Karl Marxstraat 35, 307b D.P., Rotterdam, The Netherlands

    W.H. Birkenhäger & P.W. de Leeuw

Authors
  1. W.H. Birkenhäger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P.W. de Leeuw
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Birkenhäger, W., de Leeuw, P. How Far Should Blood Pressure Be Lowered?. Drugs 36, 7–10 (1988). https://doi.org/10.2165/00003495-198836010-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198836010-00002

Search

Navigation